Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Generate Biomedicines, Inc. (GENB) had Return on Equity of -11.99% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
7.22M |
|
-69.19M |
|
-- |
|
7.22M |
|
71.34M |
|
-64.11M |
|
2.43M |
|
-61.69M |
|
-61.69M |
|
-61.71M |
|
-61.71M |
|
-61.71M |
|
-61.71M |
|
-64.11M |
|
-60.98M |
|
64.87M |
|
64.87M |
|
-1.07 |
|
-1.07 |
|
| Balance Sheet Financials | |
535.39M |
|
27.84M |
|
90.35M |
|
625.74M |
|
58.39M |
|
2.22M |
|
52.55M |
|
110.94M |
|
514.80M |
|
514.80M |
|
514.80M |
|
128.19M |
|
| Cash Flow Statement Financials | |
-80.39M |
|
-259.93M |
|
378.89M |
|
126.04M |
|
164.61M |
|
38.57M |
|
6.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.17 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-887.49% |
|
-887.49% |
|
-- |
|
-853.90% |
|
-957.85% |
|
-19.17M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-11.99% |
-11.99% |
|
-9.86% |
|
-11.94% |
|
4.02 |
|
-0.30 |
|
-1.24 |
|